Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 22

The DOI matches its Crossref record.

Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells

Brito, Jose L.R., Davies, Faith E., Gonzalez, David, Morgan, Gareth J. · 2008 · Journal of Immunological Methods

Abstract

RNA interference (RNAi) has been shown to be a valuable tool to specifically target gene expression in a number of organisms becoming an indispensable weapon in the arsenal in functional genomics. In this study, we demonstrate that streptolysin-O (SLO) reversible permeabilisation is an efficient method to deliver small interfering RNAs (siRNAs) to hard-to-transfect human myeloma cell lines. We used published, pre-validated siRNAs for ERK2 and non-silencing siRNA control. We transfected siRNAs into human myeloma cell lines using SLO reversible permeabilisation method. Flow cytometry and western blot analysis were performed to assess the effect of SLO on transfection efficiency and ERK2 knockdown. These experiments demonstrate that SLO reversible permeabilisation method is an efficient and easy-to-use method to deliver siRNAs into human myeloma cell lines. Optimised SLO permeabilisation method showed to transfect >80% of JIM-3, H929, RPMI8226 and U266 cells, with minimal effect on cell viability (<10%) and cell cycle. Equally important, SLO permeabilisation induced a substantial knockdown of ERK2 at the protein level. These studies demonstrate that reversible SLO permeabilisation can successfully be applied to hard-to-transfect human myeloma cell lines to effectively silence genes.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jim.2008.01.009

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 16

  1. Clark, 1999, Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemia, Bone Marrow Transplant., 23, 1303, 10.1038/sj.bmt.1701801 · doi:10.1038/sj.bmt.1701801
  2. Croonquist, 2005, The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype, Oncogene, 24, 6269, 10.1038/sj.onc.1208771 · DOI · Paper page
  3. Duncan, 1975, Effect of streptolysin O on erythrocyte membranes, liposomes, and lipid dispersions. A protein-cholesterol interaction, J. Cell. Biol., 67, 160, 10.1083/jcb.67.1.160 · DOI
  4. Fire, 1999, RNA-triggered gene silencing, Trends Genet., 15, 358, 10.1016/S0168-9525(99)01818-1 · DOI · Paper page
  5. Giles, 1995, Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells, Nucleic Acids Res., 23, 954, 10.1093/nar/23.6.954 · DOI
  6. Giles, 1998, Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells, Nucleic Acids Res., 26, 1567, 10.1093/nar/26.7.1567 · DOI
  7. Gomez-Benito, 2007, Mechanism of apoptosis induced by IFN-alpha in human myeloma cells: role of Jak1 and Bim and potentiation by rapamycin, Cell. Signal., 19, 844, 10.1016/j.cellsig.2006.10.009 · doi:10.1016/j.cellsig.2006.10.009
  8. Guo, 2006, The effect of cyclin D2 shRNA on the proliferation and apoptosis of LP-1 cell, Zhonghua Xue Ye Xue Za Zhi, 27, 666
  9. Haughton, 2006, Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro, Gastroenterology, 131, 194, 10.1053/j.gastro.2006.04.012 · DOI
  10. Hurt, 2004, Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma, Cancer Cell., 5, 191, 10.1016/S1535-6108(04)00019-4 · DOI · Paper page
  11. Moulding, 2000, Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells, Blood, 96, 1756, 10.1182/blood.V96.5.1756 · doi:10.1182/blood.v96.5.1756
  12. Palmer, 1998, Assembly mechanism of the oligomeric streptolysin O pore: the early membrane lesion is lined by a free edge of the lipid membrane and is extended gradually during oligomerization, Embo J., 17, 1598, 10.1093/emboj/17.6.1598 · DOI
  13. Sandy, 2005, Mammalian RNAi: a practical guide, Biotechniques, 39, 215, 10.2144/05392RV01 · DOI
  14. Spiller, 1998, Improving the intracellular delivery and molecular efficacy of antisense oligonucleotides in chronic myeloid leukemia cells: a comparison of streptolysin-O permeabilization, electroporation, and lipophilic conjugation, Blood, 91, 4738, 10.1182/blood.V91.12.4738 · DOI
  15. Tuschl, 2002, Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy, Mol. Interv., 2, 158, 10.1124/mi.2.3.158 · DOI · Paper page
  16. Zhu, 2005, Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma, Mol. Cancer Ther., 4, 787, 10.1158/1535-7163.MCT-04-0330 · DOI

Cited by

See all 22

Metadata

Authors
Brito, J. L. R., Davies, F. E., Gonzalez, D., & Morgan, G. J.
Venue
Journal of Immunological Methods
Publisher
Elsevier BV
Published
2008-04
Volume
333
Issue
1-2
Pages
147-155
ISSN
0022-1759
Cited by
22
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells. https://app.cochat.ai/papers/10.1016/j.jim.2008.01.009
The paper
Brito, J. L. R., Davies, F. E., Gonzalez, D., & Morgan, G. J. (2008). Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells. Journal of Immunological Methods. https://doi.org/10.1016/j.jim.2008.01.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.